Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27726
Title: Intravenous rifampicin use in the management of amanita phalloides toxicity.
Austin Authors: Zuker-Herman, Rona;Tong, Roger;Wong, Anselm Y 
Affiliation: Victorian Poisons Information Centre
Monash Toxicology and Emergency Department, Monash Health, Heidelberg, Australia
Toxicology
Emergency
Issue Date: Sep-2021
metadata.dc.date: 2021-02-19
Publication information: Clinical Toxicology 2021; 59(9): 843-845
Abstract: Context: Amanita phalloides related toxicity from amatoxins can result in acute liver and multi-organ failure and is responsible for 90% of all mushroom poisoning death. However, more evidence is needed in regards to different management strategies.Case details: We present two cases of amanita mushroom ingestion who were treated with intravenous rifampicin.Discussion: Further study is needed to establish the efficacy and role of rifampicin in amatoxin related mushroom poisoning.
URI: https://ahro.austin.org.au/austinjspui/handle/1/27726
DOI: 10.1080/15563650.2021.1887492
ORCID: 0000-0002-6817-7289
PubMed URL: 33605821
Type: Journal Article
Subjects: Liver
antimicrobials
gut and hepatotoxicity
other
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.